Fate therapeutics to present at the 10th annual svb leerink global healthcare conference

San diego, feb. 22, 2021 (globe newswire) -- fate therapeutics, inc. (the “company” or “fate therapeutics”) (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, announced today that the company will present at the upcoming 10th annual svb leerink healthcare conference on thursday, february 25, 2021, at 5:00 p.m. est.
FATE Ratings Summary
FATE Quant Ranking